San Jose, CA, United States of America

Andrew A Berlin

USPTO Granted Patents = 73 

 

Average Co-Inventor Count = 3.2

ph-index = 28

Forward Citations = 2,431(Granted Patents)


Inventors with similar research interests:


Location History:

  • Palo Alto, CA (US) (1997 - 2000)
  • San Jose, CA (US) (1998 - 2016)
  • Lexington, MA (US) (2018)

Company Filing History:


Years Active: 1997-2018

Loading Chart...
Loading Chart...
73 patents (USPTO):

Title: Andrew A. Berlin: Innovator in Biosensing Technologies

Introduction: Andrew A. Berlin, based in San Jose, CA, is a prolific inventor recognized for his significant contributions to the field of biosensors. With an impressive portfolio of 72 patents, Berlin has focused on developing systems and methods for detecting biomolecules, showcasing his commitment to advancing technology in both healthcare and scientific research.

Latest Patents: Among his latest innovations is a groundbreaking patent for a biosensor utilizing a resonator with a functionalized surface. This invention provides an efficient method for detecting the presence of biomolecules in a sample. The device features a piezoelectric resonator whose functionalized surface is engineered to interact with target biomolecules. This interaction modifies the mass and/or charge of the resonator, which in turn alters its frequency response. The frequency response of the resonator post-exposure is then compared to a reference, enabling accurate detection of biomolecules.

Career Highlights: Andrew A. Berlin has spent a significant portion of his career working with prominent technology companies, including Intel Corporation and Xerox Corporation. His experiences at these organizations have greatly influenced his innovative journey, allowing him to apply his theoretical knowledge to practical applications in cutting-edge technologies.

Collaborations: Throughout his career, Berlin has had the opportunity to collaborate with notable colleagues, including Mineo Yamakawa and Warren Bruce Jackson. These collaborations have facilitated the exchange of ideas and further enhanced the development of innovative biosensing technologies.

Conclusion: Andrew A. Berlin stands out as a key figure in the realm of biosensing innovation, with his extensive patent portfolio reflecting his dedication to technological advancement. His work not only contributes to the field of biosensors but also opens new avenues for detecting and analyzing biomolecules, thereby impacting healthcare and research institutions significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…